Your search for "ibd" return 12 results.
Ceva “State of the Art” Summit at VIV Asia 2015 >
Ceva’s poultry, swine, services & equipment teams will focus on what is “State of the Art” in animal production during the VIV Asia international trade show to be held in Bangkok from March 11th - 13t...
Ceva confesses its love for healthy chickens >
Ceva will attend IPPE from 28 - 30 January 2014
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva’s growth continues despite difficult market conditions >
Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. C...
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time
Ceva presents a complete range of vector vaccines at IPE 2013 >
Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.
The Perfect Pair is now available >
A great innovation in the protection against Newcastle and Gumboro Diseases
Ceva will launch the “Perfect Pair” for hatchery vaccination at World Poultry Congress >
Great innovation to be launched at 24th WPC in Brazil, August 5-9 2012
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion